These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 19269520)
1. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Quirke P; Steele R; Monson J; Grieve R; Khanna S; Couture J; O'Callaghan C; Myint AS; Bessell E; Thompson LC; Parmar M; Stephens RJ; Sebag-Montefiore D; ; Lancet; 2009 Mar; 373(9666):821-8. PubMed ID: 19269520 [TBL] [Abstract][Full Text] [Related]
2. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Sebag-Montefiore D; Stephens RJ; Steele R; Monson J; Grieve R; Khanna S; Quirke P; Couture J; de Metz C; Myint AS; Bessell E; Griffiths G; Thompson LC; Parmar M Lancet; 2009 Mar; 373(9666):811-20. PubMed ID: 19269519 [TBL] [Abstract][Full Text] [Related]
3. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W; JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375 [TBL] [Abstract][Full Text] [Related]
4. Total mesorectal excision quality in rectal cancer surgery affects local recurrence rate but not distant recurrence and survival: population-based cohort study. Collin Å; Dahlbäck C; Folkesson J; Buchwald P BJS Open; 2024 Jul; 8(4):. PubMed ID: 39113260 [TBL] [Abstract][Full Text] [Related]
5. How do we manage early rectal cancer? A national questionnaire survey among members of the ACPGBI after the preliminary results of the MRC CR07/NCIC CO16 randomized trial. Srinivasaiah N; Joseph B; Mackey P; Monson JR Colorectal Dis; 2008 May; 10(4):357-62. PubMed ID: 17764532 [TBL] [Abstract][Full Text] [Related]
6. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ; Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621 [TBL] [Abstract][Full Text] [Related]
7. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy. Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533 [TBL] [Abstract][Full Text] [Related]
8. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980 [TBL] [Abstract][Full Text] [Related]
9. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919 [TBL] [Abstract][Full Text] [Related]
10. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer. Madbouly KM; Hussein AM; Abdelzaher E Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995 [TBL] [Abstract][Full Text] [Related]
11. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925 [TBL] [Abstract][Full Text] [Related]
12. Circumferential resection margin as a prognostic marker in the modern multidisciplinary management of rectal cancer. Nikberg M; Kindler C; Chabok A; Letocha H; Shetye J; Smedh K Dis Colon Rectum; 2015 Mar; 58(3):275-82. PubMed ID: 25664704 [TBL] [Abstract][Full Text] [Related]
13. Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. Stephens RJ; Thompson LC; Quirke P; Steele R; Grieve R; Couture J; Griffiths GO; Sebag-Montefiore D J Clin Oncol; 2010 Sep; 28(27):4233-9. PubMed ID: 20585099 [TBL] [Abstract][Full Text] [Related]
14. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427 [TBL] [Abstract][Full Text] [Related]
15. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Kapiteijn E; Marijnen CA; Nagtegaal ID; Putter H; Steup WH; Wiggers T; Rutten HJ; Pahlman L; Glimelius B; van Krieken JH; Leer JW; van de Velde CJ; N Engl J Med; 2001 Aug; 345(9):638-46. PubMed ID: 11547717 [TBL] [Abstract][Full Text] [Related]
18. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer. Lin Y; Lin H; Xu Z; Zhou S; Chi P J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538 [No Abstract] [Full Text] [Related]
19. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial). Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S; BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382 [TBL] [Abstract][Full Text] [Related]
20. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]